JENNIFER O'SULLIVAN: Open Payments
NPI 1497492326 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 26 payments from 10 companies in 2025. Trend: 2023 $391 · 2024 $416 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $167 |
| Novo Nordisk Inc | 4 | $73 |
| ABBVIE INC. | 4 | $71 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Corium, LLC | 2 | $22 |
| Amgen Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: REZDIFFRA, CAPLYTA, Cologuard Collection Kit, TZIELD, Ozempic, TRELEGY ELLIPTA, Azstarys, EMBLAVEO.
Industry payments across NY — which companies pay providers there.
